Skip to main content

Mary C. Beckerle, Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Exelixis, Inc. publishes a filing, an earnings call transcript or a press release.

Get EXEL alerts

About Mary C. Beckerle, Ph.D.

Mary C. Beckerle, Ph.D. is recorded as Board Member at Exelixis, Inc. (EXEL) since May 30, 2024. Exelixis, Inc. reported in an 8-K filed May 29, 2026 a re-election or new board role (Director) for Mary C. Beckerle, Ph.D., on the board since at least 2024, effective May 26, 2026. Exelixis, Inc. reported in an 8-K filed January 8, 2024 that Mary C. Beckerle, Ph.D. was appointed Board of Directors, effective January 5, 2024. Exelixis, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Exelixis, Inc. includes Michael M. Morrissey (CEO and Board Member), Michael Morrissey (CEO and Board Member), Christopher Senner (CFO) and 7 others.

“Exelixis stockholders elected the following 11 directors to serve until the next annual meeting of stockholders in 2027, and until his or her successor is elected and qualified, or until his or her earlier death, resignation or removal”
Exelixis, Inc. Form 8-K, filed May 29, 2026 · Read the filing
“On January 5, 2024, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Exelixis, the Board increased the size of the Board to 13 members and appointed Mary C. Beckerle, Ph.D. and S. Gail Eckhardt, M.D. to the Board to fill the newly created vacancies, effective immediately.”
Exelixis, Inc. Form 8-K, filed January 8, 2024 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2024-05-30–present

Leadership on record at Exelixis, Inc.

Recent activity